Catalyst Wire Dossier Catalyst Wire Dossier

recombinant Factor VIIa BI

recombinant Factor VIIa BI · Baxalta (now part of Shire)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant Factor VIIa BI, covering 2016-10-25 to 2016-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen [Phase 3]

See pricing